Device
CryoSpray Ablation
CryoSpray Ablation is a medical device with 4 clinical trials. Historical success rate of 25.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
25.0%
Based on 1 completed trials
Completion Rate
25%(1/4)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
3(75%)
Phase Distribution
Ph phase_4
1
25%
Ph early_phase_1
1
25%
Ph not_applicable
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
25.0%
1 of 4 finished
Non-Completion Rate
75.0%
3 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Terminated(3)
Detailed Status
Terminated3
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
25.0%
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)
Trials by Status
terminated375%
completed125%
Recent Activity
0 active trials
Showing 4 of 4
terminated
Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer
NCT00321958
terminatedphase_4
Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
NCT00747461
terminatednot_applicable
CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)
NCT00748085
completedearly_phase_1
Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers
NCT00650988
Clinical Trials (4)
Showing 4 of 4 trials
NCT00321958
Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer
NCT00747461Phase 4
Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
NCT00748085Not Applicable
CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)
NCT00650988Early Phase 1
Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4